Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
Stingl
G
G
Department of Dermatology, University of Vienna Medical School, Austria.
Bröcker
E B
EB
Mertelsmann
R
R
Wolff
K
K
Schreiber
S
S
Kämpgen
E
E
Schneeberger
A
A
Trcka
J
J
Brennscheidt
U
U
Veelken
H
H
Birnstiel
M L
ML
Zatloukal
K
K
Maass
G
G
Wagner
E
E
Buschle
M
M
Kempe
E R
ER
Weber
H A
HA
Voigt
T
T
D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D002985:Clinical Protocols; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D007376:Interleukin-2 / Q000235:genetics*; D008545:Melanoma / Q000235:genetics / Q000628:therapy*
D019496:Cancer Vaccines; D007376:Interleukin-2